Sampre Nutritions (BSE:530617) - Stock Price, News & Analysis

530617 Stock Overview

Sampre Nutritions Limited manufactures and sells sugar confectionery products in India.

530617 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Rewards

Risk Analysis

Interest payments are not well covered by earnings

Earnings have declined by 12.1% per year over past 5 years

Does not have a meaningful market cap (₹501M)

Does not have meaningful revenue (₹320M)

Sampre Nutritions Limited Competitors

Nakoda Group of Industries

BSE:541418

₹694.8m

Universal Starch-Chem Allied

BSE:524408

₹737.7m

Diligent Industries

BSE:531153

₹625.5m

Terai Tea

BSE:530533

₹593.7m

Price History & Performance

Summary of all time highs, changes and price drops for Sampre Nutritions
Historical stock prices
Current Share Price	₹70.43
52 Week High	₹99.33
52 Week Low	₹46.55
Beta	-0.023
1 Month Change	4.59%
3 Month Change	-17.14%
1 Year Change	-24.40%
3 Year Change	340.46%
5 Year Change	223.07%
Change since IPO	2,415.36%

Recent updates

Shareholder Returns

	530617	IN Food	IN Market
7D	0.8%	1.3%	1.8%
1Y	-24.4%	21.2%	46.4%

Price Volatility

Is 530617's price volatile compared to industry and market?
530617 volatility
530617 Average Weekly Movement	7.2%
Food Industry Average Movement	7.0%
Market Average Movement	6.9%
10% most volatile stocks in IN Market	10.1%
10% least volatile stocks in IN Market	4.2%

About the Company

Founded	Employees	CEO	Website
1991	128	Brahma Gurbani	www.sampreltd.com

Sampre Nutritions Limited manufactures and sells sugar confectionery products in India. The company offers éclairs, candies, toffees, powder, and center filled products primarily to MNCs. It sells its products under Sampre brand name.

Sampre Nutritions Limited Fundamentals Summary

How do Sampre Nutritions's earnings and revenue compare to its market cap?
530617 fundamental statistics
Market cap	₹500.68m
Earnings (TTM)	-₹6.82m
Revenue (TTM)	₹320.50m

1.6x

P/S Ratio

-75.1x

P/E Ratio

Is 530617 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
530617 income statement (TTM)
Revenue	₹320.50m
Cost of Revenue	₹241.71m
Gross Profit	₹78.79m
Other Expenses	₹85.60m
Earnings	-₹6.82m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.94
Gross Margin	24.58%
Net Profit Margin	-2.13%
Debt/Equity Ratio	77.8%

How did 530617 perform over the long term?

See historical performance and comparison

530617 Stock Overview

Rewards

Risk Analysis

Sampre Nutritions Limited Competitors

BSE:541418

₹694.8m

BSE:524408

₹737.7m

BSE:531153

₹625.5m

BSE:530533

₹593.7m

Price History & Performance

Recent News & Updates

Third quarter 2024 earnings released: EPS: ₹0.29 (vs ₹0.24 in 3Q 2023)

Sampre Nutritions Limited to Report Q3, 2024 Results on Feb 12, 2024

Second quarter 2024 earnings released: EPS: ₹0.52 (vs ₹0.60 in 2Q 2023)

Sampre Nutritions Limited, Annual General Meeting, Sep 29, 2023

First quarter 2024 earnings released: ₹1.16 loss per share (vs ₹0.69 profit in 1Q 2023)

Sampre Nutritions Limited to Report Q1, 2024 Results on Aug 14, 2023

Recent updates

Third quarter 2024 earnings released: EPS: ₹0.29 (vs ₹0.24 in 3Q 2023)

Sampre Nutritions Limited to Report Q3, 2024 Results on Feb 12, 2024

Second quarter 2024 earnings released: EPS: ₹0.52 (vs ₹0.60 in 2Q 2023)

Sampre Nutritions Limited, Annual General Meeting, Sep 29, 2023

First quarter 2024 earnings released: ₹1.16 loss per share (vs ₹0.69 profit in 1Q 2023)

Sampre Nutritions Limited to Report Q1, 2024 Results on Aug 14, 2023

Full year 2023 earnings released: EPS: ₹0.61 (vs ₹0.64 in FY 2022)

Sampre Nutritions Limited to Report Q4, 2023 Results on May 30, 2023

Third quarter 2023 earnings released: EPS: ₹0.24 (vs ₹0.45 in 3Q 2022)

Sampre Nutritions Limited to Report Q3, 2023 Results on Feb 09, 2023

Insufficient new directors

Investor sentiment deteriorated over the past week

Sampre Nutritions Limited announced that it has received INR 97.2 million in funding from Foresight Holdings Private Limited, Delta Infragalaxy LLP, and other investors

Investor sentiment improved over the past week

Sampre Nutritions Limited, Annual General Meeting, Sep 29, 2022

Sampre Nutritions Limited to Report Q1, 2023 Results on Aug 06, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Sampre Nutritions Limited to Report Q4, 2022 Results on May 28, 2022

Insufficient new directors

Investor sentiment improved over the past week

Insufficient new directors

Investor sentiment improved over the past week

Insufficient new directors

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹0.16 (vs ₹0.70 in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS ₹0.40 (vs ₹0.27 in 3Q 2020)

Sampre Nutritions Limited to Report Q3, 2021 Results on Feb 12, 2021

New 90-day high: ₹24.45

New 90-day high: ₹22.95

Market bids up stock over the past week

New 90-day high: ₹13.98

New 90-day low: ₹9.11

Sampre Nutritions Limited to Report Q1, 2021 Results on Aug 31, 2020

New 90-day low - ₹13.19

First quarter earnings released

Shareholder Returns

Price Volatility

About the Company

Sampre Nutritions Limited Fundamentals Summary

1.6x

-75.1x

Earnings & Revenue